Oh S M, Betz A L
Department of Surgery (Neurosurgery), University of Michigan, Ann Arbor 48109-0718.
Stroke. 1991 Jul;22(7):915-21. doi: 10.1161/01.str.22.7.915.
Both oxygen free radicals and excitatory amino acids have been implicated as important cellular toxins in ischemic brain. Recent in vitro studies suggest that there may be a mutual interaction between these two mediators. We explored the relation between oxygen free radicals and excitatory amino acids in the development of ischemic brain edema in vivo. Male Sprague-Dawley rats were treated with the free radical scavenger dimethylthiourea 1 hour before ischemia or with the excitotoxin antagonist MK-801 30 minutes before ischemia produced by occlusion of the middle cerebral artery. Groups of seven or eight animals were treated with vehicle, low-dose (375 mg/kg) dimethylthiourea, high-dose (750 mg/kg) dimethylthiourea, low-dose (0.5 mg/kg) MK-801, high-dose (2.0 mg/kg) MK-801, or both high-dose dimethylthiourea and low-dose MK-801. After 4 hours of ischemia, brain water content was determined. In eight vehicle-treated controls, mean +/- SEM water content of tissue in the center of the ischemic zone was 83.29 +/- 0.18%. A significant reduction of brain edema was observed in all drug-treated groups: for example, 50.2% (p less than 0.001) in the high-dose dimethylthiourea group, 53.7% (p less than 0.001) in the low-dose MK-801 group, and 66.4% (p less than 0.001) in the combined dimethylthiourea and MK-801 group. Combined treatment with dimethylthiourea and MK-801 provided no significant additive effect over that resulting from treatment with MK-801 alone.(ABSTRACT TRUNCATED AT 250 WORDS)
氧自由基和兴奋性氨基酸都被认为是缺血性脑损伤中重要的细胞毒素。最近的体外研究表明,这两种介质之间可能存在相互作用。我们在体内研究了氧自由基与兴奋性氨基酸在缺血性脑水肿发生过程中的关系。雄性Sprague-Dawley大鼠在大脑中动脉闭塞所致缺血前1小时用自由基清除剂二甲基硫脲治疗,或在缺血前30分钟用兴奋性毒素拮抗剂MK-801治疗。将7或8只动物分为几组,分别给予溶媒、低剂量(375mg/kg)二甲基硫脲、高剂量(750mg/kg)二甲基硫脲、低剂量(0.5mg/kg)MK-801、高剂量(2.0mg/kg)MK-801,或高剂量二甲基硫脲与低剂量MK-801联合治疗。缺血4小时后,测定脑含水量。在8只接受溶媒治疗的对照组中,缺血区中心组织的平均含水量±标准误为83.29±0.18%。在所有药物治疗组中均观察到脑水肿明显减轻:例如,高剂量二甲基硫脲组减轻50.2%(p<0.001),低剂量MK-801组减轻53.7%(p<0.001),二甲基硫脲与MK-801联合治疗组减轻66.4%(p<0.001)。二甲基硫脲与MK-801联合治疗与单独使用MK-801治疗相比,没有显著的叠加效应。(摘要截短至250字)